| Code | 0229E | ||||||||||
| MA number | 52/0114/16-S | ||||||||||
| Product Form: | sir 1x200 ml (fľ.skl.tmavá+odmer.striek.10 ml) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Dr. Max Pharma s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 52 - EXPECTORANTIA, MUCOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 09.03.2016 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Ambroxol Dr.Max 30mg-5ml_04-2022.pdf
|
| PIL: |
PIL_Ambroxol Dr.Max 30mg-5ml_04-2022.pdf
|
| Safety feature | No |
| Data update: | 06.04.2022 |
